Glenmark Pharmaceuticals Ltd. | GLENMARK | NSE - Pharmaceuticals


Performance Valuation Growth Insiders Summary Balance Sheet Income Statement Cash Flow Quarterly
INR in Million. Fiscal year ends in March. Figures are consolidated and restated..

Upgrade Membership to see 10 year accurate financial statements.
 Chart
2017
2018
2019
2020
2021
Net Income
Net Income
14,914
11,193
13,006
10,961
13,825
Cash flow Operating Act...
Cash flow Operating Activities
6,57416,48113,24213,92411,312
Investments in PPE
Investments in PPE
-7,485-10,446-12,372-9,314-7,748
Cash flow Investing Act...
Net cash used for Investment Activities
-7,123-10,133-6,990-7,835-6,752
Dividend Paid
Dividend Paid
678679679686704
Cash flow Financing Act...
Net cash provided by Financing Activities
5,432-4,685-7,387-4,447-4,418
Cash at beginning of period
Cash at beginning of period
8,57110,56412,3349,36311,103
Cash at end of period
Cash at end of period
10,56412,3349,36311,10311,381
Free Cash Flow
Free Cash Flow
-911
6,034
870
4,610
3,565